Rienk Offringa

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Network Analysis

Top Venues

Science signaling

Nature reviews. Drug discovery

Science translational medicine

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Zibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan, Laura K Steffens, Hannes Kehm, Stefan Zens, Claudia Lauenstein, Alina Paul, Marius Schwab, Jonas D Förster, Mogjiborahman Salek, Angelika Beate Riemer, Heshui Wu, Christoph Eckert, Carl-Stephan Leonhardt, Oliver Strobel, Michael Volkmar, Isabel C Poschke, Rienk Offringa
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer. Science translational medicine 15 (722) (2023)
Daniel Baumann, Jennifer Drebant, Tanja Hägele, Luisa Burger, Clara Serger, Claudia Lauenstein, Przemyslaw Dudys, Gerrit Erdmann, Rienk Offringa
p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition. Journal for immunotherapy of cancer 9 (7) (2022)
Rienk Offringa, Lisa Kötzner, Bayard Huck, Klaus Urbahns
The expanding role for small molecules in immuno-oncology. Nature reviews. Drug discovery 21 (11) (2022)
Vanessa Zurli, Tommaso Montecchi, Raphael Heilig, Isabel C Poschke, Michael Volkmar, Giuliana Wimmer, Gioia Boncompagni, Gabriele Turacchio, Mario Milco D'Elios, Giuseppe Campoccia, Nicoletta Resta, Rienk Offringa, Roman Fischer, Oreste Acuto, Cosima Tatiana Baldari, Anna Kabanova
Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells. Science signaling 13 (631) (2020)